XCKQLCQZIHRGOS-QXBVICIYSA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 8uAM9Phkbg6 |
|---|---|
| InChI | InChI=1S/C18H24O3/c1-17(2)11-6-7-18(3)15(11)16(17)14-12(20-5)8-10(19-4)9-13(14)21-18/h8-9,11,15-16H,6-7H2,1-5H3/t11?,15?,16?,18-/m0/s1 |
| InChIKey | XCKQLCQZIHRGOS-QXBVICIYSA-N |
| Mol Weight | 288.39 g/mol |
| Molecular Formula | C18H24O3 |
| Exact Mass | 288.172545 g/mol |
| Enantiomer InChIKey | XCKQLCQZIHRGOS-HQWOJMSFSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
ITXIHEUMAQMSJE-LWVUGBLDSA-N
1-Hydroxy-3-(N-methyl-alpha-propyl-succinimide-alpha-yl)-6,6,9-trimethyl-6a,10a-trans-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran
11-Hydroxy-tetrahydrocannabinol-D3 2TMS
3alpha,17-bis-trimethylsilyloxy-6alpha-methyl-5beta-androstan-16-ene
3beta,17-bis-trimethylsilyloxy-6alpha-methyl-5beta-androstan-16-ene
Methyl (16.alpha.)-16,17-Dihydroxy-ent-atisan-19-oate
(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(2R)-2-methyloxiran-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Spiro[2H-1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-6,8-dicarboxaldehyde, 3,4-dihydro-5,7-dimethoxy-6',6'-dimethyl-4-(2-methylpropyl)-, [1'R-[1'.alpha.,2'.beta.(S*),5'.alpha.]]-
Spiro[2H-1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-6,8-dicarboxaldehyde, 3,4-dihydro-5,7-dimethoxy-6',6'-dimethyl-4-(2-methylpropyl)-, [1'R-[1'.alpha.,2'.alpha.(R*),5'.alpha.]]-
27-Norcholest-5-en-22-yne-3,20-diol, (3.beta.)-
| Title | Journal or Book | Year |
|---|---|---|
| Carbon-13 nuclear magnetic resonance spectra of cannabichromene, cannabicitran, and cannabicyclol and their analogs | The Journal of Organic Chemistry | 1984 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.